Microfluidic paper-based analytical devices (μPADs) have garnered significant interest as a
promising analytical platform in the past decade. Compared with traditional microfluidics …

Acute heart failure (AHF) is a syndrome defined as the new onset (de novo heart failure
(HF)) or worsening (acutely decompensated heart failure (ADHF)) of symptoms and signs of …

Background and Purpose: Natriuretic peptides have led the way as a diagnostic and
prognostic tool for the diagnosis and management of heart failure (HF). More recent …

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American
College of Cardiology Foundation/American Heart Association Task Force on Practice …

1.1. Methodology and Evidence Review The recommendations listed in this document are,
whenever possible, evidence based. An extensive evidence review was conducted through …

The purpose of this focused update is to update the “2013 ACCF/AHA Guideline for the
Management of Heart Failure” 9 (2013 HF guideline) in areas in which new evidence has …

Heart failure (HF) biomarkers have dramatically impacted the way HF patients are evaluated
and managed. B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are the …

Background—Biomarkers for predicting cardiovascular events in community-based
populations have not consistently added information to standard risk factors. A limitation of …

Cardiovascular diseases (CVDs) cause significant mortality globally. Notably, CVDs
disproportionately negatively impact underserved populations, such as those that are …

Soluble suppression of tumorigenesis-2 (sST2) is released in response to vascular
congestion and inflammatory and pro-fibrotic stimuli, and is a strong, independent predictor …